Tilray Brands (TSE:TLRY) Stock Price Expected to Rise, Sanford C. Bernstein Analyst Says

Tilray Brands (TSE:TLRY) had its target price increased by analysts at Sanford C. Bernstein from C$13.00 to C$13.60 in a note issued to investors on Friday,BayStreet.CA reports. Sanford C. Bernstein’s price target indicates a potential downside of 11.17% from the stock’s current price.

Tilray Brands Stock Down 9.7%

Shares of TSE TLRY opened at C$15.31 on Friday. The stock has a market cap of C$1.78 billion, a P/E ratio of -0.63 and a beta of 3.56. The business’s fifty day simple moving average is C$16.38 and its 200-day simple moving average is C$13.86. Tilray Brands has a 12-month low of C$4.90 and a 12-month high of C$32.30. The company has a current ratio of 2.54, a quick ratio of 2.16 and a debt-to-equity ratio of 10.76.

Tilray Brands Company Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.